This inventor holds 1 USPTO granted patent and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Evox Therapeutics Ltd, Oxford University Innovation Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 485 
Years Active: 2022
Title: The Innovative Journey of Justin Hean
Introduction
Justin Hean, an accomplished inventor based in Oxford, GB, has made significant contributions to the field of therapeutic polypeptides through his innovative research and patent. With a keen understanding of extracellular vesicle (EV) technology, his work explores groundbreaking methods for delivering therapeutic agents to target cells effectively.
Latest Patents
Justin Hean holds a patent titled "Exosomes Comprising Therapeutic Polypeptides." This invention introduces a novel release mechanism for EV-mediated intracellular and intramembrane delivery of therapeutic polypeptides. It specifically pertains to EVs that include polypeptide constructs, which feature a therapeutic polypeptide that is releasably attached to an exosomal polypeptide. The patent also encompasses manufacturing methods, pharmaceutical compositions, medical uses, and various applications associated with these innovative EVs.
Career Highlights
Throughout his career, Justin has demonstrated a strong commitment to advancing scientific knowledge and applying it to real-world challenges. He has worked at reputable organizations, including Evox Therapeutics Ltd and Oxford University Innovation Limited, where he honed his expertise in therapeutic developments and contributed to various groundbreaking projects.
Collaborations
Justin has collaborated with esteemed colleagues such as Imre Mager and Matthew Wood, further enhancing his innovative endeavors. These partnerships highlight his ability to work within multidisciplinary teams, fostering an environment of creativity and shared vision in the pursuit of new medical breakthroughs.
Conclusion
In summary, Justin Hean stands out as a visionary inventor in the realm of therapeutic polypeptides, with his patent addressing critical delivery challenges in medicine. His work at prominent institutions and collaborations with fellow researchers indicate a profound dedication to innovation in healthcare, marking him as a significant figure in the advancement of therapeutic technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile